VNDA Vanda Pharmaceuticals Inc.
Healthcare$6.22+0.48%ClosedMarket Cap: $374.0M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$14.25
Target (Median)
$14.25
Target Range
$7.50 - $21.00
Upside from current price: 129.1%
Rating Distribution
0 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-23 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-05 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-31 | B. Riley Securities | maintain | Buy | Buy |
| 2025-12-31 | Jefferies | maintain | Hold | Hold |
| 2025-11-19 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-30 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2025-08-21 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.87 | $356.3M | 4 |
| Sun Dec 31 | $-0.62 | $425.4M | 3 |
| Mon Dec 31 | $-0.05 | $509.1M | 1 |
| Tue Dec 31 | $0.68 | $563.8M | 1 |